IRF5 and triple-A syndrome: Consistent with the results from Irf5-deficient mice, AAA progression induced by elastase perfusion or CaPO4 treatment for 2 weeks was also delayed in Irf5ΔMΦ mice, compared with the littermate Irf5fl/fl mice (Figure 2, A and B, and Supplemental Figure 6, A and B).